4.7 Article

Aetiology of, and risk factors for, recurrent community-acquired pneumonia

期刊

CLINICAL MICROBIOLOGY AND INFECTION
卷 15, 期 11, 页码 1033-1038

出版社

ELSEVIER SCI LTD
DOI: 10.1111/j.1469-0691.2009.02918.x

关键词

Chronic obstructive pulmonary disease; community-acquired pneumonia; pneumococcal pneumonia; pneumococcal vaccination; recurrence

资金

  1. Ministerio de Sanidad y Consumo [REIPI RD06/0008]
  2. Institute de Salud Carlos III
  3. Spanish Network for the Research in Infectious Diseases
  4. Fondo de Investigacio n Sanitaria de la Seguridad Social [04/0139]
  5. Institut d'Investigacio Biomedica de Bellvitge (Garcia-Vidal)

向作者/读者索取更多资源

P>Recurrent community-acquired pneumonia (CAP) requiring hospitalization is a matter of particular concern. However, current information on its prevalence, aetiology and risk factors is lacking. To address these issues, we performed an observational analysis of a prospective cohort of hospitalized adults with CAP. Recurrence was defined as two or more episodes of CAP 1 month apart within 3 years. Patients with severe immunosuppression or local predisposing factors were excluded. Of the 1556 patients, 146 (9.4%) had recurrent CAP. The most frequent causative organism was Streptococcus pneumoniae, both in patients with recurrent CAP and in those without recurrence. Haemophilus influenzae, other Gram-negative bacilli and aspiration pneumonia were more frequent among patients with recurrent CAP, whereas Legionella pneumophila was rarely identified in this group. Independent factors associated with recurrent CAP were greater age, lack of pneumococcal vaccination, chronic obstructive pulmonary disease (COPD) and corticosteroid therapy. In a sub-analysis of 389 episodes of pneumococcal pneumonia, the only independent risk factor for recurrence was lack of pneumococcal vaccination. Recurrence of CAP is not a rare clinical problem and it occurs mainly in the elderly, patients with COPD, and those receiving corticosteroids. Our study provides support for recommending pneumococcal vaccination for adults at risk of pneumonia, including those with a first episode of CAP.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据